Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1977 1
1980 1
1985 1
1987 1
1988 2
1989 1
1990 3
1992 1
1993 6
1994 2
1995 2
1996 4
1997 5
1998 8
1999 9
2000 10
2001 17
2002 13
2003 15
2004 29
2005 20
2006 31
2007 31
2008 32
2009 39
2010 35
2011 39
2012 40
2013 58
2014 83
2015 97
2016 113
2017 120
2018 153
2019 156
2020 142
2021 207
2022 220
2023 195
2024 71

Text availability

Article attribute

Article type

Publication date

Search Results

1,736 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for emma first
Search for Emma Forst instead (2 results)
Odevixibat: First Approval.
Deeks ED. Deeks ED. Drugs. 2021 Oct;81(15):1781-1786. doi: 10.1007/s40265-021-01594-y. Drugs. 2021. PMID: 34499340 Free PMC article. Review.
Odevixibat (Bylvay) is a small molecule inhibitor of the ileal bile acid transporter being developed by Albireo Pharma, Inc. for the treatment of various cholestatic diseases, including progressive familial intrahepatic cholestasis (PFIC). In July 2021, odevixibat received its …
Odevixibat (Bylvay) is a small molecule inhibitor of the ileal bile acid transporter being developed by Albireo Pharma, Inc. for the treatme …
Abrocitinib: First Approval.
Deeks ED, Duggan S. Deeks ED, et al. Drugs. 2021 Dec;81(18):2149-2157. doi: 10.1007/s40265-021-01638-3. Drugs. 2021. PMID: 34807428 Free PMC article. Review.
This article summarizes the milestones in the development of abrocitinib leading to this first approval for the treatment of moderate-to-severe AD....
This article summarizes the milestones in the development of abrocitinib leading to this first approval for the treatment of moderate …
An Update of Pharmacological Management in Children with Functional Constipation.
de Geus A, Koppen IJN, Flint RB, Benninga MA, Tabbers MM. de Geus A, et al. Paediatr Drugs. 2023 May;25(3):343-358. doi: 10.1007/s40272-023-00563-0. Epub 2023 Mar 20. Paediatr Drugs. 2023. PMID: 36941393 Free PMC article. Review.
Pharmacological treatment consists of disimpaction, maintenance treatment, and eventually weaning if possible. Polyethylene glycol is considered as the first choice of laxative for both disimpaction and maintenance treatment. ...
Pharmacological treatment consists of disimpaction, maintenance treatment, and eventually weaning if possible. Polyethylene glycol is consid …
Casirivimab/Imdevimab: First Approval.
Deeks ED. Deeks ED. Drugs. 2021 Nov;81(17):2047-2055. doi: 10.1007/s40265-021-01620-z. Drugs. 2021. PMID: 34716907 Free PMC article. Review.
In February 2021, casirivimab/imdevimab was granted a positive scientific opinion in the EU for the treatment of COVID-19. In July 2021, casirivimab/imdevimab received its first approval in Japan for the treatment of mild or moderate COVID-19, followed in August 2021 by it …
In February 2021, casirivimab/imdevimab was granted a positive scientific opinion in the EU for the treatment of COVID-19. In July 2021, cas …
Ndufs4 knockout mouse models of Leigh syndrome: pathophysiology and intervention.
van de Wal MAE, Adjobo-Hermans MJW, Keijer J, Schirris TJJ, Homberg JR, Wieckowski MR, Grefte S, van Schothorst EM, van Karnebeek C, Quintana A, Koopman WJH. van de Wal MAE, et al. Brain. 2022 Mar 29;145(1):45-63. doi: 10.1093/brain/awab426. Brain. 2022. PMID: 34849584 Free PMC article. Review.
With respect to the latter, mutations in subunit-encoding genes and assembly factors of the first OXPHOS complex (complex I) induce isolated complex I deficiency and Leigh syndrome. ...
With respect to the latter, mutations in subunit-encoding genes and assembly factors of the first OXPHOS complex (complex I) induce i …
Sarecycline: First Global Approval.
Deeks ED. Deeks ED. Drugs. 2019 Feb;79(3):325-329. doi: 10.1007/s40265-019-1053-4. Drugs. 2019. PMID: 30659422 Free PMC article. Review.
This article summarizes the milestones in the development of sarecycline leading to this first approval for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris....
This article summarizes the milestones in the development of sarecycline leading to this first approval for the treatment of inflamma …
Is being the first ever 'better' than being the best?
Luscombe E. Luscombe E. Expert Opin Pharmacother. 2014 May;15(7):i-ii. doi: 10.1517/14656566.2014.906940. Epub 2014 Mar 25. Expert Opin Pharmacother. 2014. PMID: 24666337 No abstract available.
First seizure presentations in adults: beyond assessment and treatment.
Foster E, Carney P, Liew D, Ademi Z, O'Brien T, Kwan P. Foster E, et al. J Neurol Neurosurg Psychiatry. 2019 Sep;90(9):1039-1045. doi: 10.1136/jnnp-2018-320215. Epub 2019 Apr 4. J Neurol Neurosurg Psychiatry. 2019. PMID: 30948624 Review.
Accidents, injuries and death associated with first seizures are likely under-reported. The cognitive and emotional impact of first seizures is often neglected. ...It examines the effect of first seizures on the well-being of patients; assesses morbidity and …
Accidents, injuries and death associated with first seizures are likely under-reported. The cognitive and emotional impact of firs …
International clinical guideline for the management of classical galactosemia: diagnosis, treatment, and follow-up.
Welling L, Bernstein LE, Berry GT, Burlina AB, Eyskens F, Gautschi M, Grünewald S, Gubbels CS, Knerr I, Labrune P, van der Lee JH, MacDonald A, Murphy E, Portnoi PA, Õunap K, Potter NL, Rubio-Gozalbo ME, Spencer JB, Timmers I, Treacy EP, Van Calcar SC, Waisbren SE, Bosch AM; Galactosemia Network (GalNet). Welling L, et al. J Inherit Metab Dis. 2017 Mar;40(2):171-176. doi: 10.1007/s10545-016-9990-5. Epub 2016 Nov 17. J Inherit Metab Dis. 2017. PMID: 27858262 Free PMC article. Review.
A systematic review of the literature was performed, after key questions were formulated during an initial GalNet meeting. The first author and one of the working group experts conducted data-extraction. ...
A systematic review of the literature was performed, after key questions were formulated during an initial GalNet meeting. The first …
Polatuzumab Vedotin: First Global Approval.
Deeks ED. Deeks ED. Drugs. 2019 Sep;79(13):1467-1475. doi: 10.1007/s40265-019-01175-0. Drugs. 2019. PMID: 31352604 Free PMC article. Review.
This article summarizes the milestones in the development of polatuzumab vedotin leading to this first approval for its use in combination with bendamustine plus rituximab for relapsed/refractory DLBCL....
This article summarizes the milestones in the development of polatuzumab vedotin leading to this first approval for its use in combin …
1,736 results